Medical science liaison

Recent Study Indicates that Life Science Companies Can Better Leverage CRM Data

Thursday, April 8, 2021 - 2:00pm

While clear progress has been made, opportunities still remain for life science companies to better leverage data and analytics as it relates to their engagements with healthcare professionals (HCPs) - particularly within the medical affairs function.

Key Points: 
  • While clear progress has been made, opportunities still remain for life science companies to better leverage data and analytics as it relates to their engagements with healthcare professionals (HCPs) - particularly within the medical affairs function.
  • (1)
    Alucio, a fast-growing provider of cloud-based software for the life sciences industry, is addressing this gap by helping life science companies more effectively capture and leverage relevant information from HCP engagements taking place on its Beacon scientific exchange platform.
  • Jessica Wong, Alucio's VP - Product Management & Strategy, commented, "Life science companies have never suffered from a lack of customer data.
  • (1) "Survey - Utilization of Customer Relationships Management (CRM) Systems by MSLs", Medical Science Liaison Society, September 20, 2020 - October 9, 2020

ACMA Conducted Congressional Briefing on Public Health Imperative of Pharmaceutical Industry Standards for Medical Affairs Professionals

Thursday, March 25, 2021 - 8:00pm

The growing demands on pharmaceutical Medical Affairs professionals and MSLs as a critical interface between the health care companies and stakeholders including physicians and patients emphasizes the need to standardize and certify core competencies and practices across Medical Affairs teams.

Key Points: 
  • The growing demands on pharmaceutical Medical Affairs professionals and MSLs as a critical interface between the health care companies and stakeholders including physicians and patients emphasizes the need to standardize and certify core competencies and practices across Medical Affairs teams.
  • Board certifying Medical Affairs and MSL professionals is critical to ensuring ethical practices, compliance excellence, and public trust at this crucial time.
  • The ACMA developed the first board certification ever for Medical Affairs professionals and Medical Science Liaisons in 2015, and its Board Certified Medical Affairs Specialist (BCMAS) program is now considered the industry standard in the pharmaceutical industry.
  • The company's flagship Board Certified Medical Affairs Specialist (BCMAS) professional certification program for MSLs and Medical Affairs professionals is the industry standard now in over 70 countries.

Avadel Pharmaceuticals Appoints Dr. Jennifer Gudeman as Vice President of Medical and Clinical Affairs

Monday, December 7, 2020 - 1:00pm

In this role her responsibilities will include overseeing all medical and clinical affairs activities, including the companys lead program, once-nightly FT218.

Key Points: 
  • In this role her responsibilities will include overseeing all medical and clinical affairs activities, including the companys lead program, once-nightly FT218.
  • Jennifer is an accomplished medical leader and is joining Avadel at a critical juncture as we expand Avadels focus to include the scientific, clinical and market preparation activities for FT218, said Greg Divis, Chief Executive Officer of Avadel.
  • Dr. Gudeman brings approximately 20 years of pharmaceutical industry-specific, medical and clinical affairs experience to Avadel.
  • Prior to joining Avadel, Dr. Gudeman was Vice President, Medical Affairs at AMAG Pharmaceuticals, overseeing a team of medical science liaisons and scientific communications.

Physician Key Opinion Leaders (KOLs) Embrace Virtual Meetings with Field Medical Professionals During COVID-19 Pandemic

Wednesday, August 12, 2020 - 2:00pm

Physician Key Opinion Leaders (KOLs) are also embracing the technology as a way to stay engaged in scientific exchange with life science companies.

Key Points: 
  • Physician Key Opinion Leaders (KOLs) are also embracing the technology as a way to stay engaged in scientific exchange with life science companies.
  • In fact, a recent study published by The Medical Science Liaisons Society found that 77% of KOLs were somewhat to very receptive to engaging with Medical Science Liaisons (MSLs) virtually.
  • Moreover, the same study also found that 66% were interested in continuing to meet virtually with MSLs beyond the COVID-19 pandemic.
  • In addition to its virtual meeting capability, Beacon includes a host of other well thought out features for MSLs and other field medical professionals.

PharmaForce International: MSL Engagement Tactics for Leading US Pharmaceutical Companies Continue to Change Dramatically

Tuesday, August 4, 2020 - 6:07pm

The study focuses on leading pharmaceutical companies' strategies for leveraging the field medical function and captures many key findings surrounding the market.

Key Points: 
  • The study focuses on leading pharmaceutical companies' strategies for leveraging the field medical function and captures many key findings surrounding the market.
  • Some noteworthy findings are the major changes happening to the industry's engagement tactics.
  • Select pharmaceutical companies have significantly increased their field presence across traditional Medical Science Liaisons (MSLs), payer-facing MSLs, and field Health Economics and Outcomes Research (HEOR) initiatives.
  • PharmaForce International (PFI) is a competitive intelligence firm with over two decades of experience in the pharmaceutical and biotech industries.

Alucio™ Releases its Beacon Content Management and Presentation Platform for the Life Science Industry

Thursday, July 30, 2020 - 2:00pm

SAN FRANCISCO, July 30, 2020 /PRNewswire-PRWeb/ -- Alucio, a fast-growing provider of cloud-based software for the life sciences industry, today announced the release of its signature product called Beacon - a content management and presentation platform designed specifically for Medical Science Liaisons (MSLs) and other field medical professionals.

Key Points: 
  • SAN FRANCISCO, July 30, 2020 /PRNewswire-PRWeb/ -- Alucio, a fast-growing provider of cloud-based software for the life sciences industry, today announced the release of its signature product called Beacon - a content management and presentation platform designed specifically for Medical Science Liaisons (MSLs) and other field medical professionals.
  • Flexible and smart file management, with powerful search and filtering capability, enables users to find the content they need quickly and efficiently.
  • "We are tremendously excited about the launch of Beacon and the value it can provide to life science customers," stated Dave Gulezian, Alucio Co-founder and CEO.
  • Alucio's flagship product, Beacon, is a cloud-based content management and presentation platform that enhances scientific exchange between life science companies and healthcare professionals.

Emmaus Life Sciences Accelerates Middle East and North Africa (MENA) Growth Strategy with Opening of its Dubai Office

Thursday, July 23, 2020 - 6:14pm

TORRANCE, Calif., July 23, 2020 (GLOBE NEWSWIRE) -- Emmaus Life Sciences, Inc. (OTCQB: EMMA), a leader in sickle cell disease treatment, announced today the opening of its regional office in Dubai.

Key Points: 
  • TORRANCE, Calif., July 23, 2020 (GLOBE NEWSWIRE) -- Emmaus Life Sciences, Inc. (OTCQB: EMMA), a leader in sickle cell disease treatment, announced today the opening of its regional office in Dubai.
  • The Dubai office will be utilized to enhance Emmaus relationships with clinicians and patient groups at major hospitals and other government-sponsored health care facilities in communities throughout the Middle East and North Africa (MENA) region.
  • As product registration and marketing authorization are obtained, deploy local medical science liaisons (MSLs) and account managers to call on local hospitals and clinics.
  • Such forward-looking statements speak only as of the date they are made, and Emmaus assumes no duty to update them, except as may be required by law.

ACMA Announces New Investment and Expansion in the Asian Life Sciences Market

Tuesday, June 9, 2020 - 6:16pm

The ACMA has also established a leadership council to represent the interests of medical affairs professionals in China, India, Indonesia, Japan, Malaysia, the Philippines, Singapore, South Korea, Taiwan, and Vietnam along with other Asian countries.

Key Points: 
  • The ACMA has also established a leadership council to represent the interests of medical affairs professionals in China, India, Indonesia, Japan, Malaysia, the Philippines, Singapore, South Korea, Taiwan, and Vietnam along with other Asian countries.
  • "The pharmaceutical market has grown significantly in Asia and we are now seeing a rapid increase in the numbers of companies hiring medical science liaisons (MSLs) and medical affairs professionals," said ACMA Founder and CEO, Dr. William Soliman.
  • The ACMA developed the first board certification ever for MSLs and medical affairs professionals in 2015 and its Board Certified Medical Affairs Specialist (BCMAS) program is now considered the industry standard in the pharma world.
  • For more information about the need for global standards of excellence in medical affairs, visit https://www.MedicalAffairsSpecialist.org/

OptimizeRx Launches TelaRep™ to Support Physicians Treating Patients with Complex Diseases in COVID-19 World 

Thursday, April 2, 2020 - 1:31pm

Before COVID-19 and social distancing, physicians treating patients with complex diseases could consult with medical science liaisons (MSLs) in their offices to ensure the appropriate treatment plan.

Key Points: 
  • Before COVID-19 and social distancing, physicians treating patients with complex diseases could consult with medical science liaisons (MSLs) in their offices to ensure the appropriate treatment plan.
  • Now that COVID-19 severely restricts these face-to-face interactions, there is a critical communication gap that can put patients at risk.
  • In order to design the best therapeutic treatment regimen for their patients, healthcare providers need detailed information about these powerful specialty medications.
  • TelaRep is available to all life science companies that subscribe to the OptimizeRx integrated communications platform.

Medical Science Liaison Society Launches First-Ever Professional Board Certification for Medical Science Liaisons (MSL) and MSL Leaders

Monday, February 24, 2020 - 3:11pm

RALEIGH, N.C., Feb. 24, 2020 /PRNewswire/ -- The Medical Science Liaison Society (MSL Society), the only 501c3 non-profit organization exclusively dedicated to the global medical science liaison (MSL) profession, announced today that it has launched the first-ever professional board certification for Medical Science Liaisons (MSL) and MSL leaders.

Key Points: 
  • RALEIGH, N.C., Feb. 24, 2020 /PRNewswire/ -- The Medical Science Liaison Society (MSL Society), the only 501c3 non-profit organization exclusively dedicated to the global medical science liaison (MSL) profession, announced today that it has launched the first-ever professional board certification for Medical Science Liaisons (MSL) and MSL leaders.
  • The Medical Science Liaison - Board Certification (MSL-BC) program, which has been in development for the last several years, is an effort to set industry recognized standards for the MSL profession.
  • The MSL Society hired a certification industry testing leader to help launch a credible program based on international certification standards.
  • The Medical Science Liaison Society is the primary global resource for MSL professionals.